One study investigated the relationship between pre-treatment and the early on-treatment detection of BRAF, NRAS and KIT alterations in ctDNA using ddPCR and treatment outcome in 76 melanoma patients treated with nivolumab alone or in combination with ipilimumab [96]. This evidence concerns the gene KIT and melanoma.